Pfizer Inc.
235 East 42nd Street
New York,
NY 10017
Phone: 212-573-2323
Fax: 212-573-7851
Web Site: http://www.pfizer.com
| Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimers disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The companys Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York. |
|
| Key Statistics |
|
|
|
| |
Pay |
Exercised |
Mr. Jeffrey B. Kindler , 54
Chairman, Chief Exec. Officer, Chairman of Exec. Committee and Chairman of Exec. Compliance Committee
|
$
4.58M |
$
0 |
Mr. Frank A. D'Amelio , 52
Chief Financial Officer, Sr. VP of Bus. Operations and Member of Exec. Compliance Committee
|
$
2.30M |
$
0 |
Mr. Ian C. Read , 56
Group Pres of Worldwide Biopharmaceutical Bus.es and Member of Exec. Compliance Committee
|
$
2.30M |
$
0 |
Mr. Martin Mackay , 53
Pres of PharmaTherapeutics R&D
|
$
2.29M |
$
0 |
Mr. Natale S. Ricciardi , 61
Pres of Manufacturing
|
N/A
|
N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
|
|
|
Help
0.04 (0.22%) 
Profile
